Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance


Koksal A. S. , Onder F. O. , Torun S., Parlak E., Sayilir A., Tayfur O., et al.

ACTA GASTRO-ENTEROLOGICA BELGICA, cilt.76, ss.34-37, 2013 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 76 Konu: 1
  • Basım Tarihi: 2013
  • Dergi Adı: ACTA GASTRO-ENTEROLOGICA BELGICA
  • Sayfa Sayısı: ss.34-37

Özet

Background/Aims : Bismuth-containing quadruple therapy given four times a day is effective in the first-line treatment of Helicobacter pylori. We aimed to investigate whether twice daily posology could eradicate H. pylori at a comparable rate in an area with a high prevalence of antibiotic resistance.